Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray, Chest pain, Echocardiogram, Pulmonary function test, Rash
Clinical narrative: chest pain; itching rash; This is a spontaneous report received from contactable reporter(s) (Other HCP) from medical information team for a Pfizer sponsored program.  A 41 year-old female patient received bnt162b2 (BNT162B2), administration date 28Jan2021 16:00 (Lot number: EN5318) at the age of 41 years as dose 1, 0.3 ml single for covid-19 immunisation. Relevant medical history included: "hypertension" (ongoing); "Hypothyroidism" (ongoing). There were no concomitant medications. Past drug history included: Keflex, reaction(s): "Allergic to Keflex". The following information was reported: RASH (non-serious) with onset 28Jan2021, outcome "unknown", described as "itching rash"; CHEST PAIN (non-serious), outcome "unknown", described as "chest pain". The events "itching rash" and "chest pain" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of rash.  Additional information: Caller clarified that she was a Nurse and called to report this patient was administered 1 dose of Pfizer-BioNTech Covid-19 Vaccine on 28Jan2021 and developed adverse allergic reaction including itching rash, chest pain with diagnosis of acute bronchitis. Nurse called to ask if there is any way that the patient can obtain exemption forms for the Pfizer-BioNTech Covid-19 Vaccine because of this experience if Pfizer can provide a form like that. Time of onset provided as 30 minutes after Pfizer-BioNTech Covid-19 Vaccine, later provided from notes as immediately following administration of Pfizer-BioNTech Covid-19 Vaccine on 28Jan2021 patient developed itching rash across her body and cheeks. They called dr. office who advised her to take Prednisone and an Antihistamine and if symptoms progressed to go to the emergency room. The patient's symptoms progressed to the point that she had to go to emergency room for the itching rash and chest pain. She was evaluated and released from the emergency room where she was diagnosed with acute bronchitis related to chest x-ray performed while at the emergency room at "Privacy". She also had a pulmonary function test which was normal and the same as the pulmonary function test done by prior pulmonologist. Caller mentioned that the telehealth notes from 11Feb2021 note 2 weeks ago after receiving first dose of Pfizer-BioNTech Covid-19 Vaccine patient got the rash 30 minutes after first dose. Outcome and seriousness criteria unknown by reporter, they were just calling it adverse reaction; they saw her for the first time in Mar2021, when she was seeking a second opinion after different pulmonologist was seen. Caller's site released her 22May2021. Patient called them back because her job was mandating that she get additional dose of Pfizer-BioNTech Covid-19 Vaccine, so she called to ask for exemption information. The adverse events were resulted in emergency room and physician office. The patient was not admitted to hospital, seen in emergency room. Follow-up attempts are completed. No further information is expected.